Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIEN(®)) in Patients with Diabetic Macular Edema

INTRODUCTION: Patients with diabetic macular edema (DME), a chronic, vision-limiting condition, may be insufficiently responsive to standard-of-care anti-vascular endothelial growth factor (VEGF) and/or laser therapies. One approved treatment for such patients is 0.2 μg/day fluocinolone acetonide (F...

Descripción completa

Detalles Bibliográficos
Autores principales: Elaraoud, Ibrahim, Attawan, Alaa, Quhill, Fahd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909672/
https://www.ncbi.nlm.nih.gov/pubmed/26885863
http://dx.doi.org/10.1007/s40123-016-0045-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909672/
https://www.ncbi.nlm.nih.gov/pubmed/26885863
http://dx.doi.org/10.1007/s40123-016-0045-7

Ejemplares similares